Multi-System Analysis of Opioid Receptor Binding

PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 20, 2022

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
HealthyOpioid Use Disorder
Interventions
DRUG

Carfentanil, C-11

Investigational radiotracer to be injected by IV as s a bolus during both study PET/CT scans.

DRUG

Naloxone

Non-selective opioid antagonist injected by IV parenterally during the second study PET/CT scan only.

DRUG

Loperamide Hydrochloride

Loperamide is an FDA- approved, over-the-counter drug for the control and symptomatic relief of acute or chronic diarrhea given orally prior to the optional HC third PET/CT scan only.

Trial Locations (1)

19104

RECRUITING

University of Pennsylvania, Perelman School of Medicine, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER